Oxaliplatin combined with 5-fluorouracil and methotrexate in advanced colorectal cancer.

Zampino, M G; Lorizzo, K; Rocca, A; Locatelli, M; Zorzino, L; Manzoni, S; Mazzetta, C; Fazio, N; Biffi, R; De Braud, F

Zampino, M G; Lorizzo, K; Rocca, A; Locatelli, M; Zorzino, L; Manzoni, S; Mazzetta, C; Fazio, N; Biffi, R; De Braud, F.

Affiliation

Zampino MG; Division of Medical Oncology, European Institute of Milan, 20141 Milan, Italy. maria.zampino@ieo.it

Anticancer Res ; 26(3B): 2425-8, 2006.

Article in En | MEDLINE | ID: mdl-16821627

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Colorectal Neoplasms/drug therapy; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Colorectal Neoplasms/blood; Drug Administration Schedule; Female; Fluorouracil/administration & dosage; Fluorouracil/adverse effects; Humans; Infusions, Intravenous; Male; Methotrexate/administration & dosage; Methotrexate/adverse effects; Middle Aged; Organoplatinum Compounds/administration & dosage; Organoplatinum Compounds/adverse effects; Oxaliplatin; Vascular Endothelial Growth Factor A/blood

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Anticancer Res Year: 2006 Type: Article Affiliation country: Italy

Search on Google

XML

PubMed Links